| Literature DB >> 31975751 |
George Grunberger1, David Sze2, Anastasia Ermakova2, Ray Sieradzan2, Teresa Oliveria2, Eden M Miller3.
Abstract
An online survey was conducted to assess the perspectives and use of diabetes technologies by a sample of U.S. primary care physicians (PCPs) and endocrinologists to optimize intensive insulin therapy in patients with type 2 diabetes. Overall, endocrinologists reported using diabetes technologies more frequently than PCPs for patients with type 2 diabetes requiring basal-bolus insulin therapy. PCPs and endocrinologists who were highly focused on diabetes management with insulin therapy reported using insulin delivery devices (insulin pumps and wearable tube-free patches) when patients are not achieving their A1C target while taking basal plus three or more prandial injections of insulin daily.Entities:
Year: 2020 PMID: 31975751 PMCID: PMC6969667 DOI: 10.2337/cd19-0008
Source DB: PubMed Journal: Clin Diabetes ISSN: 0891-8929